e-Drug3D 1644 |
cas 106941-25-7 |
CLASS ANTIINFECTIVES |
ROUTE (list) - |
ATC code |
PK parameters F 59 PERCENT |
Target TARGET HBV REVERSE TRANSCRIPTASE PDB Ligand code = 5HG (link to the list of PDB complexes) Download experimental 3D coordinates of 5HG with added hydrogens |
DrugCentral Protein P UNIPROT Q9IF40 P |
Download SDF file | 2-(6-amino-9h-purin-9-yl)ethoxy]methylphosphonic acid Formula: Calculated chemical properties: MW 271.18 NB_atoms 18 XLogP -1.70 PSA 125.277 NB_HD 2 NB_HA 9 fsp3 0.38 Lipinski(0=no;1=yes) 1 |
FDA - |
Other links: | |
e-Drug3D 904 |
cas 142340-99-6 |
CLASS ANTIINFECTIVES |
ROUTE (list) ORAL |
ATC code |
PK parameters Solubility 0.4 MILLIGRAM / MILLILITER AT PH 7.2 |
Target TARGET HBV REVERSE TRANSCRIPTASE |
DrugCentral Protein P UNIPROT Q9IF40 P |
Download SDF file | [2-(6-aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate Formula: Calculated chemical properties: MW 501.48 NB_atoms 34 XLogP 2.70 PSA 158.168 NB_HD 2 NB_HA 13 fsp3 0.65 Lipinski(0=no;1=yes) 0 |
FDA NDA 021449 (label) INN (ADEFOVIR DIPIVOXIL) HEPSERA (GILEAD) APPROVAL= AP YEAR= 2002 DISCONTINUED NDA 202051 (label) INN (ADEFOVIR DIPIVOXIL) ADEFOVIR DIPIVOXIL (SIGMAPHARM LABS LLC) APPROVAL= AP YEAR= 2013 NDA 205459 (pdf not found) INN (ADEFOVIR DIPIVOXIL) ADEFOVIR DIPIVOXIL (APOTEX) APPROVAL= AP YEAR= 2018 |
Other links: |